Pricing Log in Create free account
Saturday 17 October 2026 Export HSIC’s income statement to Excel — free account

Henry Schein, Inc.

HSIC Healthcare Medical Distribution

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

86.38 0.61 −0.70%
Market cap
$9.7B
P/E
25.0×
Fwd P/E
18.5×
Dividend yield
—
F-score
5/9
Altman Z
2.66
Beneish M
−2.51
Dividend safety
69/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Henry Schein, Inc. (HSIC) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Henry Schein, Inc. (HSIC) trades at a price to free cash flow of 17.2×. Over the past ten years it has ranged from 9.7× (April 2020) to 29.8× (February 2024); the current reading is higher than 37% of that period. That is below the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 15.9× 27.14%
FY2024 12.5× (55.17%)
FY2023 28.0× 30.62%
FY2022 21.4× 24.35%
FY2021 17.2× (0.64%)
FY2020 17.3× 1.50%
FY2019 17.1× 11.37%
FY2018 15.3× (15.75%)
FY2017 18.2× 5.34%
FY2016 17.3× (8.64%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 16.7× (12.52%)
Mar 2026 19.0× 19.46%
Dec 2025 15.9× (19.50%)
Sep 2025 19.8× (15.77%)
42 more quarters

Against its own ten years

Low 9.7× High 29.8×
Ten-year median 17.9×
Current reading's percentile 37

Price to free cash flow against peers

Company Price to free cash flow
HKPD Cellyan Biotechnology Co., Ltd compare n/m
ACH Accendra Health, Inc. compare n/m
FOCL FocalTherics compare n/m
AHG Akso Health Group Sponsored ADR compare n/m
COSM Cosmos Health Inc. compare n/m
CAH Cardinal Health, Inc. compare 13.2×
COR Cencora, Inc. compare 16.0×
HSIC Henry Schein, Inc. 17.2×
MCK McKesson Corporation compare 19.5×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on HSIC